By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 ...
AdvaMed supports the legislation, which is intended to ensure AI-enabled devices receive an accurate CMS payment code.
Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost ...
The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...
The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...
GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal ...
The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer ...
Peichel, who has worked at Medtronic for more than 25 years, succeeds Ken Washington, who retired earlier this month.
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston ...
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...
Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する